| Literature DB >> 29614131 |
Farah Rahman1, Jun Guan1, Richard H Glazier1,2,3,4,5, Adalsteinn Brown2,4,5, Arlene S Bierman1,6,7, Ruth Croxford1, Therese A Stukel1,4,8,9.
Abstract
One of the more fundamental health policy questions is the relationship between health care quality and spending. A better understanding of these relationships is needed to inform health systems interventions aimed at increasing quality and efficiency of care. We measured 65 validated quality indicators (QI) across Ontario physician networks. QIs were aggregated into domains representing six dimensions of care: screening and prevention, evidence-based medications, hospital-community transitions (7-day post-discharge visit with a primary care physician; 30-day post-discharge visit with a primary care physician and specialist), potentially avoidable hospitalizations and emergency department (ED) visits, potentially avoidable readmissions and unplanned returns to the ED, and poor cancer end of life care. Each domain rate was computed as a weighted average of QI rates, weighting by network population at risk. We also measured overall and sector-specific per capita healthcare network spending. We evaluated the associations between domain rates, and between domain rates and spending using weighted correlations, weighting by network population at risk, using an ecological design. All indicators were measured using Ontario health administrative databases. Large variations were seen in timely hospital-community transitions and potentially avoidable hospitalizations. Networks with timely hospital-community transitions had lower rates of avoidable admissions and readmissions (r = -0.89, -0.58, respectively). Higher physician spending, especially outpatient primary care spending, was associated with lower rates of avoidable hospitalizations (r = -0.83) and higher rates of timely hospital-community transitions (r = 0.81) and moderately associated with lower readmission rates (r = -0.46). Investment in effective primary care services may help reduce burden on the acute care sector and associated expenditures.Entities:
Mesh:
Year: 2018 PMID: 29614131 PMCID: PMC5882137 DOI: 10.1371/journal.pone.0195222
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Quality indicator rates, according to quality domain.
| Quality Indicator | Risk Adjustment | Median | 10th to 90th Percentiles | Ratio of 90th to 10th Percentiles | Interclass Correlation Coefficient (ICC) |
|---|---|---|---|---|---|
| 64.9 | 60.4–68.1 | 1.13 | 0.007 | ||
| Eye examination for individuals with diabetes | Unadjusted | 69.5 | 66.1–74.7 | 1.13 | 0.014 |
| Cholesterol testing for individuals with diabetes | Unadjusted | 87.9 | 84.2–90.0 | 1.07 | 0.028 |
| HbA1c testing for individuals with diabetes | Unadjusted | 41.7 | 36.1–50.6 | 1.40 | 0.020 |
| Optimal screening (eye examination, cholesterol test, HbA1c test) for individuals with diabetes | Unadjusted | 34.1 | 30.0–42.5 | 1.42 | 0.018 |
| Bone mineral density test, eligible females | Unadjusted | 83.9 | 74.2–90.3 | 1.22 | 0.083 |
| Bone mineral density test after a fracture, males | Age-sex | 11.7 | 6.0–16.9 | 2.82 | 0.036 |
| Bone mineral density test after a fracture, females | Age-sex | 20.4 | 12.9–25.8 | 2.00 | 0.029 |
| Mammogram, eligible females | Unadjusted | 66.9 | 62.4–71.1 | 1.14 | 0.007 |
| Pap test, eligible females | Unadjusted | 72.1 | 68.4–77.0 | 1.13 | 0.012 |
| Colorectal cancer screening, eligible individuals | Unadjusted | 61.2 | 55.8–67.4 | 1.21 | 0.015 |
| Post-stroke therapy provided as a part of home care | Age-sex | 65.0 | 43.4–79.1 | 1.82 | 0.086 |
| 75.0 | 72.7–77.8 | 1.07 | 0.003 | ||
| ACE or ARB after AMI hospitalization | Age-sex | 79.4 | 72.9–84.5 | 1.16 | 0.014 |
| Beta-blocker after AMI hospitalization | Age-sex | 79.5 | 71.8–84.3 | 1.17 | 0.022 |
| Statin after AMI hospitalization | Age-sex | 89.4 | 84.9–93.9 | 1.11 | 0.026 |
| ACE or ARB after CHF hospitalization | Age-sex | 69.8 | 61.9–74.9 | 1.21 | 0.009 |
| Beta-blocker after CHF hospitalization | Age-sex | 69.5 | 61.5–76.1 | 1.24 | 0.018 |
| Statin after CHF hospitalization | Age-sex | 63.7 | 55.9–69.4 | 1.24 | 0.013 |
| Antihypertensive after stroke hospitalization | Age-sex | 84.9 | 77.2–90.3 | 1.17 | 0.023 |
| Statin after stroke hospitalization | Age-sex | 76.7 | 70.0–84.7 | 1.21 | 0.017 |
| ACE or ARB for individuals with diabetes | Age-sex | 72.0 | 69.9–75.3 | 1.08 | 0.004 |
| Antihypertensive for individuals with diabetes | Age-sex | 84.5 | 82.4–86.8 | 1.05 | 0.006 |
| Statin for individuals with diabetes | Age-sex | 69.6 | 65.9–72.4 | 1.10 | 0.006 |
| 43.5 | 31.1–51.7 | 1.66 | 0.051 | ||
| Office visit | Age-sex | 45.5 | 35.4–54.7 | 1.55 | 0.025 |
| Office visit | Age-sex | 46.4 | 33.3–53.9 | 1.62 | 0.033 |
| Office visit | Age-sex | 32.0 | 19.2–39.6 | 2.06 | 0.035 |
| Office visit | Age-sex | 35.8 | 26.9–46.7 | 1.74 | 0.029 |
| Office visit, | Unadjusted | 80.2 | 55.7–87.1 | 1.56 | 0.167 |
| Office visit, | Age-sex | 46.4 | 24.3–59.3 | 2.44 | 0.085 |
| Office visit, | Age-sex | 24.3 | 13.5–31.3 | 2.32 | 0.058 |
| Shared care, | Age-sex | 8.5 | 3.8–18.7 | 4.92 | 0.060 |
| Shared care, | Age-sex | 3.9 | 1.9–5.6 | 2.95 | 0.032 |
| Shared care | Age-sex | 24.2 | 13.9–35.8 | 2.58 | 0.070 |
| Shared care | Age-sex | 27.1 | 12.9–36.4 | 2.82 | 0.092 |
| Shared care | Age-sex | 19.2 | 9.1–24.1 | 2.65 | 0.087 |
| Office visit | Age-sex | 39.7 | 28.9–48.3 | 1.67 | 0.035 |
| 11.6 | 8.3–17.6 | 2.12 | 0.018 | ||
| Hospitalization for acute complication of diabetes, % | Fully risk-adjusted | 0.5 | 0.3–0.7 | 2.33 | 0.026 |
| Hospitalization for chronic complication of diabetes, % | Fully risk-adjusted | 3.9 | 3.3–4.7 | 1.42 | 0.008 |
| Hospitalization for asthma, per 1,000 individuals with asthma | Fully risk-adjusted | 1.3 | 0.9–2.0 | 2.22 | 0.000 |
| Hospitalization for diabetes, per 1,000 individuals with diabetes | Fully risk-adjusted | 5.1 | 3.4–7.2 | 2.12 | 0.031 |
| Hospitalization for CHF, per 1,000 individuals with CHF | Fully risk-adjusted | 48.8 | 40.0–64.5 | 1.61 | 0.014 |
| Hospitalization for COPD, per 1,000 individuals with COPD | Fully risk-adjusted | 70.1 | 52.8–90.4 | 1.71 | 0.024 |
| ED visit for acute complication of diabetes, per 1,000 individuals with diabetes | Fully risk-adjusted | 29.1 | 19.7–46.2 | 2.35 | 0.052 |
| ED visit for chronic complication of diabetes, per 1,000 individuals with diabetes | Fully risk-adjusted | 12.5 | 10.1–17.2 | 1.70 | 0.015 |
| 17.9 | 16.7–19.7 | 1.18 | 0.012 | ||
| Readmission within 30 days after discharge for AMI | Fully risk-adjusted | 12.2 | 9.0–14.2 | 1.58 | 0.008 |
| Readmission within 30 days after discharge for CHF | Fully risk-adjusted | 20.0 | 16.6–24.3 | 1.46 | 0.004 |
| Readmission within 30 days after discharge for stroke | Fully risk-adjusted | 9.6 | 6.9–11.2 | 1.62 | 0.003 |
| Readmission within 30 days after discharge for psychiatric care | Fully risk-adjusted | 13.6 | 11.7–17.6 | 1.50 | 0.023 |
| ED visit within 30 days after discharge for AMI | Fully risk-adjusted | 23.0 | 20.3–29.2 | 1.44 | 0.011 |
| ED visit within 30 days after discharge for CHF | Fully risk-adjusted | 29.5 | 25.7–36.6 | 1.42 | 0.008 |
| ED visit within 30 days after discharge for stroke | Fully risk-adjusted | 17.1 | 13.5–20.8 | 1.54 | 0.004 |
| ED visit within 30 days after discharge for psychiatric care | Fully risk-adjusted | 22.8 | 19.7–27.4 | 1.39 | 0.039 |
| 30.6 | 27.0–35.6 | 1.32 | 0.016 | ||
| Died in hospital (excluding recipients of palliative care) | Unadjusted | 36.9 | 24.5–52.6 | 2.15 | 0.075 |
| No home care visit in last 6 months of life | Unadjusted | 21.3 | 16.2–27.6 | 1.70 | 0.022 |
| No palliative care in last 6 months of life | Unadjusted | 38.1 | 26.0–56.5 | 2.17 | 0.077 |
| ICU stay in last 2 weeks of life | Unadjusted | 7.3 | 5.4–9.5 | 1.76 | 0.005 |
| ED visit in last 2 weeks of life | Unadjusted | 33.9 | 29.6–41.8 | 1.41 | 0.013 |
| Chemotherapy in last 2 weeks of life | Unadjusted | 3.0 | 1.5–4.6 | 3.07 | 0.022 |
| No house call in last 2 weeks of life | Unadjusted | 78.2 | 67.1–84.9 | 1.27 | 0.061 |
| Total spending per capita, $ | Age-sex | 2,540 | 2,257–2,868 | 1.27 | |
| Hospital spending per capita, $ | Age-sex | 986 | 824–1,234 | 1.50 | |
| Total physician spending per capita, $ | Age-sex | 543 | 476–613 | 1.29 | |
| Primary care physician spending per capita, $ | Age-sex | 203 | 158–239 | 1.51 | |
| Specialist spending per capita, $ | Age-sex | 347 | 289–397 | 1.37 | |
| Prescription drug spending per capita, age 65+, $ | Age-sex | 320 | 262–369 | 1.41 | |
| Long-term care spending per capita, $ | Age-sex | 250 | 187–286 | 1.53 |
*Office visit: at least one office visit with a primary care provider or appropriate specialist. Includes visits by a physician to a patient’s home or long-term care facility, and telephone calls to a patient.
†Shared care: at least one office visit with both a primary care provider and appropriate specialist. Includes visits by a physician to a patient’s home or long-term care facility, and telephone calls to a patient.
§Based on an annualized rate.
‡Quality indicator values were weighted by the network denominators.
ACE: angiotensin converting enzyme inhibitor; ARB: angiotensin receptor blocker; AMI: acute myocardial infarction; CHF: congestive heart failure; COPD: chronic obstructive pulmonary disease; ED: emergency department; ICU: intensive care unit; ODB: Ontario Drug Benefit.
Correlations between quality domain rates.
| 1.0 | -0.06 | 0.29 | -0.31 | -0.36 | -0.38 | |
| p = 0.62 | p = 0.01 | p = 0.007 | p = 0.002 | p<0.001 | ||
| 1.0 | -0.09 | 0.11 | 0.02 | 0.07 | ||
| p = 0.46 | p = 0.37 | p = 0.87 | p = 0.53 | |||
| 1.0 | ||||||
| 1.0 | ||||||
| 1.0 | ||||||
| 1.0 |
Fig 1Rates of avoidable admissions per 1000 patients and 30-day readmissions (%) vs. timely hospital-community transitions (%).
Rates of avoidable admissions and 30-day readmissions are fully risk-adjusted across all quality indicators within these domains. Quality indicators comprising timely hospital-community transitions were all age-sex adjusted, except for office visit for a newborn within 7 days after hospital discharge.
Correlations between spending and quality domain rates.
| -0.39 | 0.12 | 0.64 | 0.50 | |||
| p<0.001 | p = 0.32 | p<0.001 | p<0.001 | |||
| -0.01 | 0.01 | -0.27 | -0.32 | |||
| p = 0.93 | p = 0.92 | p = 0.02 | p = 0.005 | |||
| -0.14 | 0.03 | -0.05 | -0.18 | |||
| p = 0.25 | p = 0.79 | p = 0.65 | p = 0.13 | |||
| -0.007 | -0.06 | -0.38 | ||||
| p = 0.95 | p = 0.63 | p = 0.001 | ||||
| 0.07 | -0.005 | -0.31 | -0.31 | |||
| p = 0.57 | p = 0.97 | p = 0.007 | p = 0.007 | |||
| -0.35 | 0.32 | 0.34 | 0.45 | |||
| p = 0.002 | p = 0.005 | p = 0.003 | p<0.001 | |||
| -0.30 | 0.23 | 0.35 | 0.48 | |||
| p = 0.008 | p = 0.05 | p = 0.002 | p<0.001 |
Fig 2Rates of avoidable admissions per 1000 patients and 30-day readmissions (%) vs. outpatient primary care spending per capita.
Rates of avoidable admissions and 30-day readmissions are fully risk-adjusted across all quality indicators within this domain. Outpatient primary care spending was age-sex adjusted.
Fig 3Timely hospital-community transitions (%) vs. outpatient primary care spending per capita.
Quality indicators comprising timely hospital-community transitions were age-sex adjusted, except for office visit for a newborn within 7 days after hospital discharge. Outpatient primary care spending per capita was age-sex adjusted.
Correlations between network characteristics and quality domain rates.
| -0.19 | 0.02 | |||||
| p = 0.11 | p = 0.89 | |||||
| -0.21 | 0.13 | |||||
| p = 0.07 | p = 0.27 | |||||
| -0.61 | 0.18 | |||||
| p<0.001 | p = 0.12 |